Stock Market logoStock Market Station

All the stock market news, every minute updated!

03 August 2021
13:27 hour

Adicet Bio launches first-in-human study of ADI-001 in blood cancer

Seeking Alpha

10/03/2021 - 13:49


READ THE FULL ARTICLE ON SEEKING ALPHA

Related headlines:

  1. Mexico Exports - Prepared Human & Animal Blood, Antisera, Others (13/02/2021 - Trading Economics)
    Exports - Prepared Human & Animal Blood, Antisera, Others in Mexico increased to 23350 USD THO in December from 16786 USD THO in November of 2020. Exports - Prepared Human & Animal Blood, Antisera, in Mexico averaged 6327.07 USD THO from 1993 until 2020, reaching an all time high of 35821 USD THO in September of 2009 and a record low of 346 USD THO in August of 1994. This page includes a chart with historical data for Mexico Exports of Prepared Human & Animal Blood, Antiser.
    [visit article]
  2. Karyopharm updates data for eltanexor in blood cancer study (09/06/2021 - Seeking Alpha)

    [visit article]
  3. Karyopharm updates data for eltanexor in blood cancer study (09/06/2021 - Seeking Alpha)

    [visit article]
  4. ImmunityBio posts results from early-stage blood cancer study (04/05/2021 - Seeking Alpha)

    [visit article]
  5. IMV to advance its lead asset with Keytruda in mid-stage blood cancer study (07/04/2021 - Seeking Alpha)

    [visit article]
  6. Geron starts dosing in late-stage blood cancer study (13/04/2021 - Seeking Alpha)

    [visit article]
  7. BeiGene reports positive results from Phase 3 Brukinsa study in blood cancer (30/07/2021 - Seeking Alpha)

    [visit article]
  8. Astellas' Xospata meets overall survival endpoint in late-stage blood cancer study (30/03/2021 - Seeking Alpha)

    [visit article]
  9. JNJ/AbbVie's Imbruvica + Venclexta show promising progression-free survival in late-stage blood cancer study (14/06/2021 - Seeking Alpha)

    [visit article]
  10. Burning Rock launches pan-cancer liquid biopsy study in China (19/05/2021 - Seeking Alpha)

    [visit article]
  11. Cancer in children: The unseen impact of cancer on education (02/08/2021 - Financial Express)
    As per a Lancet study, India alone witnesses more than 50,000 cases of cancer in children under 19 years of age every year.
    [visit article]
  12. $PPBT breaking ground with cancer. (06/06/2021 - Reddit Stocks)
    WARNING: This is a hugely manipulated stock. The amount of shorting and algorithmic trading is something to behold, truly. Interim data was released for their main cancer drug in P1. At the LOWEST dosage levels (3mg/kg) it caused remission in two cancerous lesions and stabilized two others. It’s currently being tested all the way up to 50mg/kg. This has been studied for ten years and could potentially service 26 different types of cancer. It is a small molecule that can pass the blood-brain barrier and potentially help in brain cancer. Take a look! Thanks!   submitted by   /u/CheshireLux [link]   [comments]
    [visit article]
  13. World Blood Donor Day 2021: Impact of Covid-19 on blood donation (13/06/2021 - Financial Express)
    By donating blood you can save someone's life. Blood donation stimulates Blood Cell Production. It helps you to complete your social responsibilities.
    [visit article]
  14. Mereo BioPharma and Cancer Focus Fund ink partnership for ovarian cancer study (30/04/2021 - Seeking Alpha)

    [visit article]
  15. : Getting COVID creates far higher risk of rare blood clots than vaccines, Oxford study finds (15/04/2021 - Market Watch)
    A new study from researchers at Oxford University has found that people who contract COVID-19 are at far higher risk of developing blood clots than people who receive COVID-19 vaccines, further bolstering the case for vaccine use.
    [visit article]
  16. Sony launches Bravia X90J 55-inch Ultra-HD HDR TV in India, claims it can think like a human brain (10/06/2021 - Financial Express)
    The main USP of this smart TV is its Cognitive Processor XR which, in the words of Sony, allows it to think like a human brain
    [visit article]
  17. On World Blood Donor Day, unveiling the story behind COVID-19 and blood shortage: Saving patients with Thalassemia (14/06/2021 - Financial Express)
    One would wonder as to why the topic of blood donation assumed such significance so as to warrant corrections, explanations, etc? Here is a fact which is not alien to anyone - blood services hold prime importance for urgent or elective surgical interventions and patients with rare genetic blood disorders such as thalassemia.
    [visit article]
  18. Genentech presents new data for a range of blood cancer therapies (04/06/2021 - Seeking Alpha)

    [visit article]
  19. Mustang Bio is ahead of a key catalyst in blood cancer trial: Cantor (12/05/2021 - Seeking Alpha)

    [visit article]
  20. Curis jumps after blood cancer trial indicates impressive results (12/05/2021 - Seeking Alpha)

    [visit article]
  21. FDA accepts TG Therapeutics' application for ublituximab + ukoniq in blood cancer (25/05/2021 - Seeking Alpha)

    [visit article]
  22. EMA grants PRIME tag to Autolus Therapeutics' AUTO1 in blood cancer (01/04/2021 - Seeking Alpha)

    [visit article]
  23. ADC Therapeutics reports updated Zynlonta data in blood cancer trials (18/06/2021 - Seeking Alpha)

    [visit article]
  24. Magenta Therapeutics defended at Wedbush despite setback in blood cancer trial (21/07/2021 - Seeking Alpha)

    [visit article]
  25. Incyte and MorphoSys presents new three-year data for blood cancer therapy (04/06/2021 - Seeking Alpha)

    [visit article]
  26. TG Therapeutics reports final data from ublituximab combo in blood cancer (23/02/2021 - Seeking Alpha)

    [visit article]
  27. Soligenix soars 13% after securing PIP waiver for HyBryte in blood cancer in Europe (10/06/2021 - Seeking Alpha)

    [visit article]
  28. Blood cancer player Imago BioSciences prices upsized 8.4M-share IPO at $16 (16/07/2021 - Seeking Alpha)

    [visit article]
  29. Bluebird bio pares losses after suggesting lentiviral vector didn’t cause blood cancer (26/02/2021 - Seeking Alpha)

    [visit article]
  30. Bluebird bio says lentiviral vector unlikely caused blood cancer which forced trial pause (10/03/2021 - Seeking Alpha)

    [visit article]
  31. SELLAS rated new overweight at Cantor noting the potential of blood cancer therapy (21/07/2021 - Seeking Alpha)

    [visit article]
  32. Autolus gains after announcing 100 percent complete remission in blood cancer trial (12/05/2021 - Seeking Alpha)

    [visit article]
  33. Allogene reports positive early-stage data for CAR T candidates in blood cancer (20/05/2021 - Seeking Alpha)

    [visit article]
  34. Curis plunges after selecting a lower dose for blood cancer trial due to safety concerns (11/06/2021 - Seeking Alpha)

    [visit article]
  35. Celyad Oncology presents early-stage data from blood cancer trial for CAR-T therapy (11/06/2021 - Seeking Alpha)

    [visit article]
  36. GT Biopharma announces strong early-stage safety results for blood cancer therapy (23/06/2021 - Seeking Alpha)

    [visit article]
  37. Aptevo meets primary endpoint in early-stage trial for blood cancer therapy (26/05/2021 - Seeking Alpha)

    [visit article]
  38. SPPI ???????????? some DD on this South Korean biotech’s fat duse (05/06/2021 - Reddit Stock Market)
    SPPI (Spectrum Pharmaceuticals, Inc.) $3.95 (6/4/21) Market Cap over $554 million Average Volume over 2.8 million This DD will focus on SPPI’s phase 3 drug Rolontis. SPPI filed for its BLA in December of 2019 with a PFUDA date in October 2020. At that time, the FDA informed the company that an inspection of SPPI’s Hanmi Bioplant was required before they could approve the BLA. However, travel restrictions due to the ‘Rona pandemic prevented this inspection from occurring. Only until March of this year did the FDA schedule a pre-approval inspection in May and along with encouraging news of another SPPI drug Poziotinib in Phase 2 (not discussed here), it was announced on June 1 that the FDA was on site in Hanmi and the inspection had been initiated. Now why does this matter? Let a pacifier puffing baby in a crib enlighten you, if for only a moment. Rolontis treats chemotherapy-induced neutropenia. Cancer patients are often treated with chemotherapy. Chemotherapy, as you may know, often kills healthy cells along with the actual cancerous cells in one’s body. Some of these healthy cells that are killed are white blood cells. Having fewer than normal white blood cells is known as Neutropenia. White blood cells are essential for protection against foreign germs and therefore with fewer in the bloodstream, patients with Neutropenia are more susceptible to infection. A study done between 2009 and 2011 on 291 gynecological cancer patients, of whom the average age was 60, found that chemotherapy induced Neutropenia occurred in 50.5% of the patients. Each year, about 650,000 people are treated with chemotherapy and in 2012, over 100,000 people with cancer were hospitalized due to Neutropenia. Neutropenia can be fatal as well. On average, 4000 die each year of neutropenia with fever. Rolontis has proven more effective than the existing treatment, Pegfilgrastim, in treating neutropenia. The actual efficacy of Rolontis can be read from a publication that is linked below that I will not even attempt to translate. I, in agreement with Lee Schwartzberg smarty pants, foresee Rolontis improving supportive care for patients undergoing chemotherapy. I also foresee with my undeveloped mind that SPPI will consequently bring in that dough. This is of course not financial advice, no matter what the Karen’s think. I am simply a kid in a crib with unwieldy access to the internet. Rolontis, its efficacy and superiority over Pegfilgrastim: https://www.sppirx.com/338-spectrum-products-development-rolontis.html https://www.biospace.com/article/releases/spectrum-pharmaceuticals-announces-integrated-results-from-two-phase-3-rolontis-eflapegrastim-trials-being-presented-at-the-asco-annual-meeting/ Relevance and study of neutropenia: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588600/ https://www.cdc.gov/cancer/dcpc/research/articles/neutropenia.htm https://www.cdc.gov/cancer/preventinfections/providers.htm   submitted by   /u/Manlius_Torquatus [link]   [comments]
    [visit article]
  39. Adicet Bio EPS beats by $0.42 (11/03/2021 - Seeking Alpha)

    [visit article]
  40. Adicet Bio EPS misses by $0.31 (17/05/2021 - Seeking Alpha)

    [visit article]
  41. New study links popular diet with lower blood pressure — and reduced cardiac injury and strain (25/05/2021 - Market Watch)
    ‘Our study represents some of the strongest evidence that diet directly impacts cardiac damage, and our findings show that dietary interventions can improve cardiovascular risk factors.’
    [visit article]
  42. Lexaria's DehydraTECH-CBD helps lower blood pressure in study (29/07/2021 - Seeking Alpha)

    [visit article]
  43. The New York Post: Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study (21/07/2021 - Market Watch)
    The study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J vaccine may need to receive a second shot as the variant continues to spread across the US.
    [visit article]
  44. Cannabics' RCC-33 prolongs survival rate in mice inoculated with human colorectal cancer cells (17/03/2021 - Seeking Alpha)

    [visit article]
  45. Human capital firm Paycor launches 18.5M IPO at $18-$21/share (12/07/2021 - Seeking Alpha)

    [visit article]
  46. AstraZeneca vaccine - Norwegian scientists found connection to blood clots (18/03/2021 - Reddit Stocks)
    $AZN There's a press conference live now in Norway, where the vaccine is directly connected to the the blood clots in multiple patients. The results have been sent to the EMA for further study. This might mean a hit on the stock today. https://www.nrk.no/norge/ous-forsker_-har-funnet-arsaken-til-astrazeneca-bivirkninger-1.15422689 My position in the stock: none (nor in any competitors)   submitted by   /u/FredTheDentist [link]   [comments]
    [visit article]
  47. Oxford initiating human challenge COVID-19 study (19/04/2021 - Seeking Alpha)

    [visit article]
  48. Adicet Bio joins Russell 2000 Index (28/06/2021 - Seeking Alpha)

    [visit article]
  49. Adicet Bio shares down on $135M capital raise (10/02/2021 - Seeking Alpha)

    [visit article]

For more information mailto [email protected]. Disclaimer.